A conserved, crystallographically defined bile acid binding
site
was originally identified in the membrane domain of mammalian and
bacterial cytochrome c oxidase (CcO). Current studies show other amphipathic molecules including detergents,
fatty acids, steroids, and porphyrins bind to this site and affect
the already 50% inhibited activity of the E101A mutant of Rhodobacter sphaeroides CcO as well as
altering the activity of wild-type and bovine enzymes. Dodecyl maltoside,
Triton X100, C12E8, lysophophatidylcholine, and CHOBIMALT detergents
further inhibit RsCcO E101A, with
lesser inhibition observed in wild-type. The detergent inhibition
is overcome in the presence of micromolar concentrations of steroids
and porphyrin analogues including deoxycholate, cholesteryl hemisuccinate,
bilirubin, and protoporphyrin IX. In addition to alleviating detergent
inhibition, amphipathic carboxylates including arachidonic, docosahexanoic,
and phytanic acids stimulate the activity of E101A to wild-type levels
by providing the missing carboxyl group. Computational modeling of
dodecyl maltoside, bilirubin, and protoporphyrin IX into the conserved
steroid site shows energetically favorable binding modes for these
ligands and suggests that a groove at the interface of subunit I and
II, including the entrance to the K-path and helix VIII of subunit
I, mediates the observed competitive ligand interactions involving
two overlapping sites. Spectral analysis indicates that ligand binding
to this region affects CcO activity by altering the
K-path-dependent electron transfer equilibrium between heme a and heme a3. The high affinity
and specificity of a number of compounds for this region, and its
conservation and impact on CcO activity, support
its physiological significance.